EP3534913A4 - Composition et méthode pour traiter des otites - Google Patents
Composition et méthode pour traiter des otites Download PDFInfo
- Publication number
- EP3534913A4 EP3534913A4 EP17868280.3A EP17868280A EP3534913A4 EP 3534913 A4 EP3534913 A4 EP 3534913A4 EP 17868280 A EP17868280 A EP 17868280A EP 3534913 A4 EP3534913 A4 EP 3534913A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- treating otitis
- otitis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/341,930 US20170071979A1 (en) | 2011-05-11 | 2016-11-02 | Composition and method for treating otitis |
PCT/US2017/059513 WO2018085384A1 (fr) | 2016-11-02 | 2017-11-01 | Composition et méthode pour traiter des otites |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3534913A1 EP3534913A1 (fr) | 2019-09-11 |
EP3534913A4 true EP3534913A4 (fr) | 2020-07-15 |
Family
ID=60860035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17868280.3A Withdrawn EP3534913A4 (fr) | 2016-11-02 | 2017-11-01 | Composition et méthode pour traiter des otites |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3534913A4 (fr) |
JP (3) | JP6255134B1 (fr) |
KR (3) | KR20180061359A (fr) |
CN (1) | CN108472313A (fr) |
WO (1) | WO2018085384A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021161105A (ja) * | 2020-03-31 | 2021-10-11 | タイ ミン ファーマシューティカルズ ジェイエスシー | ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物 |
WO2021198940A1 (fr) * | 2020-03-31 | 2021-10-07 | タイ ミン ファーマシューティカルズ ジェイエスシー | Composition destinée à prévenir ou soigner une infection virale chronique ou aiguë et/ou une septicémie chez l'être humain ou chez l'animal |
FR3122572A1 (fr) * | 2021-05-07 | 2022-11-11 | Nadine GRISLAIN | Composition pharmaceutique bioadhésive comprenant du PVPI |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060280809A1 (en) * | 2005-06-14 | 2006-12-14 | Leshchiner Adele K | Anti-infective iodine based compositions for otic and nasal use |
WO2013040347A1 (fr) * | 2011-09-16 | 2013-03-21 | Foresight Biotherapeutics, Inc. | Compositions stables de povidone-iode |
WO2016118424A1 (fr) * | 2015-01-20 | 2016-07-28 | Veloce Biopharma Llc | Nouvelle composition iodophore et procédés d'utilisation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241051A (en) * | 1977-11-04 | 1980-12-23 | Christie Robert B | Calcitonin |
JP2008533048A (ja) * | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 耳の感染症の治療方法 |
DE202005004183U1 (de) * | 2005-03-14 | 2005-05-25 | G. Pohl-Boskamp Gmbh & Co. Kg | Ohrentropfen zum Einbringen in den Gehörgang |
CN101002775A (zh) * | 2006-01-18 | 2007-07-25 | 广州白云山制药股份有限公司广州白云山制药总厂 | 一种抗感染制剂 |
GB0709513D0 (en) * | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
US20090263345A1 (en) * | 2008-01-28 | 2009-10-22 | Foresight Biotherapeutics, Inc. | Otic compositions for the treatment of infections of the internal and external ear in mammals |
US20100016450A1 (en) * | 2008-07-21 | 2010-01-21 | Otonomy, Inc. | Controlled release delivery devices for the treatment of otic disorders |
AR079479A1 (es) * | 2009-12-15 | 2012-01-25 | Foresight Biotherapeutics Inc | Composiciones oftalmicas no irritantes de povidona iodada |
JP2013516485A (ja) * | 2010-01-07 | 2013-05-13 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 耳にモキシフロキサシンを適用するための方法および組成物 |
PL2366408T3 (pl) * | 2010-03-01 | 2013-01-31 | Salvat Lab Sa | Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu |
JP6077527B2 (ja) * | 2011-05-11 | 2017-02-08 | ヴェローチェ・バイオファーマ・エルエルシー | 皮膚および爪の治療のための抗真菌組成物 |
WO2014159930A1 (fr) * | 2013-03-14 | 2014-10-02 | Alc Therapeutics, Llc | Compositions antimycosiques pour le traitement de surinfections de la peau et des ongles |
US9539223B2 (en) * | 2013-05-01 | 2017-01-10 | Neoculi Pty Ltd | Methods for treating bacterial infections |
-
2017
- 2017-07-21 JP JP2017141605A patent/JP6255134B1/ja not_active Expired - Fee Related
- 2017-11-01 WO PCT/US2017/059513 patent/WO2018085384A1/fr unknown
- 2017-11-01 EP EP17868280.3A patent/EP3534913A4/fr not_active Withdrawn
- 2017-11-01 KR KR1020187012808A patent/KR20180061359A/ko active Application Filing
- 2017-11-01 CN CN201780002919.6A patent/CN108472313A/zh active Pending
- 2017-11-01 KR KR1020197024236A patent/KR20190100442A/ko active Application Filing
- 2017-11-01 KR KR1020187013133A patent/KR20180059554A/ko not_active Application Discontinuation
- 2017-11-14 JP JP2017218785A patent/JP6271804B1/ja not_active Expired - Fee Related
- 2017-12-26 JP JP2017249207A patent/JP2018070655A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060280809A1 (en) * | 2005-06-14 | 2006-12-14 | Leshchiner Adele K | Anti-infective iodine based compositions for otic and nasal use |
WO2013040347A1 (fr) * | 2011-09-16 | 2013-03-21 | Foresight Biotherapeutics, Inc. | Compositions stables de povidone-iode |
WO2016118424A1 (fr) * | 2015-01-20 | 2016-07-28 | Veloce Biopharma Llc | Nouvelle composition iodophore et procédés d'utilisation |
Non-Patent Citations (3)
Title |
---|
LINDA K WONG ET AL: "Volume 46 | Issue 2 Clinical Considerations of Dimethyl Sulfoxide Recommended Citation Clinical Considerations of Dimethyl Sulfoxide", 1 January 1984 (1984-01-01), XP055700607, Retrieved from the Internet <URL:https://lib.dr.iastate.edu/cgi/viewcontent.cgi?referer=https://www.***.com/&httpsredir=1&article=3126&context=iowastate_veterinarian> [retrieved on 20200603] * |
ROSYCHUK R A W: "MANAGEMENT OF OTITIS EXTERNA", VETERINARY CLINICS OF NORTH AMERICA: SMALL ANIMAL PRACTICE, SAUNDERS, PHILADELPHIA, US, vol. 24, no. 5, 1 September 1994 (1994-09-01), pages 921 - 953, XP000670927, ISSN: 0195-5616 * |
See also references of WO2018085384A1 * |
Also Published As
Publication number | Publication date |
---|---|
KR20190100442A (ko) | 2019-08-28 |
JP6271804B1 (ja) | 2018-01-31 |
KR20180061359A (ko) | 2018-06-07 |
KR20180059554A (ko) | 2018-06-04 |
EP3534913A1 (fr) | 2019-09-11 |
JP2018070620A (ja) | 2018-05-10 |
JP6255134B1 (ja) | 2017-12-27 |
CN108472313A (zh) | 2018-08-31 |
JP2018070583A (ja) | 2018-05-10 |
JP2018070655A (ja) | 2018-05-10 |
WO2018085384A1 (fr) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3555077A4 (fr) | Compositions et procédés pour le traitement du cancer | |
EP3247359A4 (fr) | Compositions et procédés de traitement de troubles épileptiques | |
EP3532464A4 (fr) | Compositions et procédés pour le traitement du cancer à médiation par l'ezh2 | |
EP3490582A4 (fr) | Méthodes et compositions de traitement de maladie. | |
EP3681525A4 (fr) | Composition et méthode de traitement de l'autisme | |
EP3193862A4 (fr) | Composition cannabinoïde et méthode de traitement de la douleur | |
EP3277270A4 (fr) | Compositions et procédés permettant de traiter une anémie | |
EP3458158A4 (fr) | Compositions et procédés permettant de traiter l'eczéma | |
EP3704227A4 (fr) | Composition et procédé | |
EP3462883A4 (fr) | Compositions et méthodes pour le traitement du cancer | |
EP3458079A4 (fr) | Compositions et méthodes pour le traitement de l'acné | |
EP3261644A4 (fr) | Compositions et méthodes pour le traitement de dégradations de la rétine | |
EP3359663A4 (fr) | Composition et méthode de traitement d'une maladie à médiation par le complément | |
EP3528798A4 (fr) | Compositions et méthodes pour le traitement du cancer | |
EP3402575A4 (fr) | Procédés et compositions pour le traitement de cheveux endommagés | |
EP3541421A4 (fr) | Compositions et méthodes pour le traitement du cancer | |
EP3471746A4 (fr) | Méthode et composition pour traiter des troubles epileptiques | |
EP3405172A4 (fr) | Procédés et compositions pour le traitement du vieillissement cutané | |
EP3405191A4 (fr) | Méthodes et compositions pour le traitement de l'hyperhidrose | |
EP3468546A4 (fr) | Compositions et méthodes pour le traitement du cancer | |
EP3352729A4 (fr) | Méthodes et compositions de traitement de la peau | |
EP3429613A4 (fr) | Compositions et méthodes de traitement de cancers | |
EP3262065A4 (fr) | Procédés et compositions de traitement des dystroglycanopathies | |
EP3273951A4 (fr) | Compositions et procédés de traitement du psoriasis | |
HK1243635A1 (zh) | 治療皮膚病況的組合物和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190531 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200616 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 31/04 20060101ALI20200609BHEP Ipc: A61P 27/16 20060101ALI20200609BHEP Ipc: A61P 31/10 20060101ALI20200609BHEP Ipc: A61K 47/58 20170101ALI20200609BHEP Ipc: A61P 33/04 20060101ALI20200609BHEP Ipc: A61K 47/38 20060101ALI20200609BHEP Ipc: A61K 9/06 20060101ALI20200609BHEP Ipc: A61K 9/00 20060101ALI20200609BHEP Ipc: A61K 47/06 20060101ALI20200609BHEP Ipc: A61P 31/12 20060101ALI20200609BHEP Ipc: A61P 31/02 20060101ALI20200609BHEP Ipc: A61K 47/32 20060101ALI20200609BHEP Ipc: A61K 33/18 20060101AFI20200609BHEP Ipc: A61K 47/10 20170101ALI20200609BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20220601 |